Tessari Eben bought KNSA
November 26, 2025 · Form 4 insider transaction
Tessari Eben bought 200 shares of Kiniksa Pharmaceuticals International, plc at $22.89 per share, a transaction worth $4.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
200
Price
$22.89
Total value
$4.6K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateNovember 26, 2025
Filing dateDecember 1, 2025
Shares owned after22,914
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.